Sharmini Balakrishnan, MD
Ophthalmology · Louisville, KYNPI 1639306343
Payments from drug & device makers
What this record shows
17 manufacturers reported payments, led by Bausch & Lomb Americas Inc. at 54.0% of the total. Reporting peaked in 2022 at $3,524 and has fallen 89.6% since, to $365 in 2025.
Across 92 payments — averaging $60.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bausch & Lomb Americas Inc.$3K
- Glaukos Corporation$553
- Sun Pharmaceutical Industries Inc.$473
- AbbVie$362
- Alcon$293
- Bausch & Lomb, A Division Of Bausch Health US, LLC$160
- plus $706 from 11 others
What the payments were for
- Consulting fees$2,87552%
- Food & beverage$2,66948%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bausch & Lomb Americas Inc. | 8 | $2,996 |
| Glaukos Corporation | 8 | $553 |
| Sun Pharmaceutical Industries Inc. | 27 | $473 |
| AbbVie(2 entities) | 18 | $362 |
| Alcon | 7 | $293 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 5 | $160 |
| Sight Sciences, Inc. | 2 | $152 |
| NEW World Medical,inc. | 3 | $147 |
| Optos, Inc. | 1 | $117 |
| Novartis | 4 | $81 |
| Eyevance Pharmaceuticals LLC | 2 | $42 |
| Carl Zeiss Meditec, Inc. | 1 | $42 |
| Rxsight Inc | 2 | $33 |
| Beaver-visitec International, Inc. | 1 | $29 |
| Tarsus Pharmaceuticals, Inc. | 1 | $28 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $18 |
| Boston Scientific | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- iStent inject W$239
- Clareon$143
- OMNI(R) SURGICAL SYSTEM (US)$133
- P200DTx$117
- P200T$117
- P200TE$117
- P200TxE$117
How this compares
$5,544 in reported general payments places this provider in the 85th percentile of 216 ophthalmology providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 184 | $4,819 |
| MoxifloxacinMoxifloxacin Hcl | 151 | $3,006 |
| Ketorolac Tromethamine | 79 | $2,678 |
| Diclofenac Sodium | 92 | $1,128 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Louisville
- Jeremy ClarkLouisville$131K
- Guruprasad PattarLouisville$36K
- Gary FoulksLouisville$16K
- Christopher ComptonLouisville$13K
- Inder SingalLouisville$9K
- Rishi KumarLouisville$8K
- Frank BurnsLouisville$8K
- Steven BloomLouisville$6K
- Sergei DmitrukLouisville$5K
- Lawrence TenkmanLouisville$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.